Amedeo Smart

Free Medical Literature Service



Colorectal Neoplasms

  Free Subscription

Articles published in
Cancer Lett
    May 2018
  1. LI Y, Oliver PG, Lu W, Pathak V, et al
    Retraction notice to "SRI36160 is a specific inhibitor of Wnt/<beta>-catenin signaling in human pancreatic and colorectal cancer cells" [Canc. Lett. 389C (2017) 41-48].
    Cancer Lett. 2018;422:131.
    >> Share

    April 2018
  2. JIAN Y, Wang M, Zhang Y, Ou R, et al
    Jade family PHD finger 3 (JADE3) increases cancer stem cell-like properties and tumorigenicity in colon cancer.
    Cancer Lett. 2018 Apr 13. pii: S0304-3835(18)30273.
    >> Share

  3. SONG J, Wang T, Xu W, Wang P, et al
    HOXB9 acetylation at K27 is responsible for its suppression of colon cancer progression.
    Cancer Lett. 2018 Apr 11. pii: S0304-3835(18)30263.
    >> Share

    March 2018
  4. JIANG H, Li T, Qu Y, Wang X, et al
    Long non-coding RNA SNHG15 interacts with and stabilizes transcription factor Slug and promotes colon cancer progression.
    Cancer Lett. 2018 Mar 28. pii: S0304-3835(18)30241.
    >> Share

  5. BASU S, Gavert N, Brabletz T, Ben-Ze'ev A, et al
    The intestinal stem cell regulating gene ASCL2 is required for L1-mediated colon cancer progression.
    Cancer Lett. 2018 Mar 15. pii: S0304-3835(18)30219.
    >> Share

  6. TAN K, Leong SM, Kee Z, Caramat PV, et al
    Longitudinal monitoring reveals dynamic changes in circulating tumor cells (CTCs) and CTC-associated miRNAs in response to chemotherapy in metastatic colorectal cancer patients.
    Cancer Lett. 2018 Mar 5. pii: S0304-3835(18)30180.
    >> Share

    February 2018
  7. AL-HAIDARI A, Algaber A, Madhi R, Syk I, et al
    MiR-155-5p controls colon cancer cell migration via post-transcriptional regulation of Human Antigen R (HuR).
    Cancer Lett. 2018;421:145-151.
    >> Share

  8. SHUAI W, Wu J, Chen S, Liu R, et al
    SUV39H2 promotes colorectal cancer proliferation and metastasis via tri-methylation of the SLIT1 promoter.
    Cancer Lett. 2018 Feb 16. pii: S0304-3835(18)30156.
    >> Share

  9. OU C, Sun Z, Li X, Li X, et al
    Corrigendum to "MiR-590-5p, a density-sensitive microRNA, inhibits tumorigenesis by targeting YAP1 in colorectal cancer", [Canc. Lett. 399 (2017) 53-63].
    Cancer Lett. 2018 Feb 8. pii: S0304-3835(18)30106.
    >> Share

    January 2018
  10. PORCELLINI E, Laprovitera N, Riefolo M, Ravaioli M, et al
    Epigenetic and epitranscriptomic changes in colorectal cancer: diagnostic, prognostic, and treatment implications.
    Cancer Lett. 2018 Jan 19. pii: S0304-3835(18)30071.
    >> Share

  11. ZHANG S, Hu B, You Y, Yang Z, et al
    Sorting nexin 10 acts as a tumor suppressor in tumorigenesis and progression of colorectal cancer through regulating chaperone mediated autophagy degradation of p21(Cip1/WAF1).
    Cancer Lett. 2018 Jan 17. pii: S0304-3835(18)30067.
    >> Share

  12. KIM T, Croce CM
    Long noncoding RNAs: Undeciphered cellular codes encrypting keys of colorectal cancer pathogenesis.
    Cancer Lett. 2018 Jan 3. pii: S0304-3835(18)30006.
    >> Share

    December 2017
  13. KIM CW, Oh ET, Kim JM, Park JS, et al
    Hypoxia-induced microRNA-590-5p promotes colorectal cancer progression by modulating matrix metalloproteinase activity.
    Cancer Lett. 2017;416:31-41.
    >> Share

  14. BYUN MR, Hwang JH, Kim AR, Kim KM, et al
    SRC activates TAZ for intestinal tumorigenesis and regeneration.
    Cancer Lett. 2017;410:32-40.
    >> Share

  15. FANG Z, Gong C, Yu S, Zhou W, et al
    NFYB-induced high expression of E2F1 contributes to oxaliplatin resistance in colorectal cancer via the enhancement of CHK1 signaling.
    Cancer Lett. 2017 Dec 1. pii: S0304-3835(17)30765.
    >> Share

    November 2017
  16. BLEAU AM, Redrado M, Nistal-Villan E, Villalba M, et al
    miR-146a targets c-met and abolishes colorectal cancer liver metastasis.
    Cancer Lett. 2017 Nov 10. pii: S0304-3835(17)30702.
    >> Share

    October 2017
  17. KIM C, Hong Y, Lee H, Kang H, et al
    MicroRNA-195 Desensitizes HCT116 Human Colon Cancer Cells to 5-Fluorouracil.
    Cancer Lett. 2017 Oct 25. pii: S0304-3835(17)30659.
    >> Share

  18. ZHUGE W, Chen R, Vladimir K, Dong X, et al
    Costunolide specifically binds and inhibits thioredoxin reductase 1 to induce apoptosis in colon cancer.
    Cancer Lett. 2017 Oct 13. pii: S0304-3835(17)30630.
    >> Share

  19. LIANG Z, Yang Y, He Y, Yang P, et al
    SUMOylation of IQGAP1 promotes the development of colorectal cancer.
    Cancer Lett. 2017 Oct 5. pii: S0304-3835(17)30607.
    >> Share

  20. SHUKLA K, Sonowal H, Saxena A, Ramana KV, et al
    Aldose reductase inhibitor, fidarestat regulates mitochondrial biogenesis via Nrf2/HO1/AMPK pathway in colon cancer cells.
    Cancer Lett. 2017 Oct 3. pii: S0304-3835(17)30584.
    >> Share

    September 2017
  21. FANG C, Qiu S, Sun F, Li W, et al
    Long non-coding RNA HNF1A-AS1 mediated repression of miR-34a/SIRT1/p53 feedback loop promotes the metastatic progression of colon cancer by functioning as a competing endogenous RNA.
    Cancer Lett. 2017 Sep 21. pii: S0304-3835(17)30562.
    >> Share

  22. YAGDI EFE E, Mazumder A, Lee JY, Gaigneaux A, et al
    Tubulin-binding anticancer polysulfides induce cell death via mitotic arrest and autophagic interference in colorectal cancer.
    Cancer Lett. 2017 Sep 21. pii: S0304-3835(17)30561.
    >> Share

  23. LI W, Qiu T, Guo L, Ying J, et al
    Major challenges related to tumor biological characteristics in accurate mutation detection of colorectal cancer by next-generation sequencing.
    Cancer Lett. 2017 Sep 21. pii: S0304-3835(17)30564.
    >> Share

  24. SUN LN, Zhi Z, Chen LY, Zhou Q, et al
    SIRT1 suppresses colorectal cancer metastasis by transcriptional repression of miR-15b-5p.
    Cancer Lett. 2017 Sep 15. pii: S0304-3835(17)30548.
    >> Share

  25. RADHAKRISHNAN H, Ilm K, Walther W, Shirasawa S, et al
    MACC1 regulates Fas mediated apoptosis through STAT1/3 - Mcl-1 signaling in solid cancers.
    Cancer Lett. 2017;403:231-245.
    >> Share

  26. WESTDORP H, Kolders S, Hoogerbrugge N, de Vries IJM, et al
    Immunotherapy holds the key to cancer treatment and prevention in constitutional mismatch repair deficiency (CMMRD) syndrome.
    Cancer Lett. 2017;403:159-164.
    >> Share

    August 2017
  27. OTTAIANO A, Nasti G, Cassata A, De Stefano A, et al
    FOLFOXIRI in metastatic colorectal cancer: a criticism from its native land.
    Cancer Lett. 2017 Aug 24. pii: S0304-3835(17)30512.
    >> Share

  28. OBERTHUR R, Seemann H, Gehrig J, Rave-Frank M, et al
    Simultaneous inhibition of IGF1R and EGFR enhances the efficacy of standard treatment for colorectal cancer by the impairment of DNA repair and the induction of cell death.
    Cancer Lett. 2017 Aug 18. pii: S0304-3835(17)30486.
    >> Share

  29. TAGHAVI S, Ramezani M, Alibolandi M, Abnous K, et al
    Chitosan-modified PLGA nanoparticles tagged with 5TR1 aptamer for in vivo tumor-targeted drug delivery.
    Cancer Lett. 2017;400:1-8.
    >> Share

    June 2017
  30. LOW YS, Blocker C, McPherson JR, Tang SA, et al
    A formalin-fixed paraffin-embedded (FFPE)-based prognostic signature to predict metastasis in clinically low risk stage I/II microsatellite stable colorectal cancer.
    Cancer Lett. 2017;403:13-20.
    >> Share

  31. SUI H, Zhao J, Zhou L, Wen H, et al
    Tanshinone IIAinhibits beta-catenin/VEGF-mediated angiogenesis by targeting TGF-beta1 in normoxic and HIF-1alphainhypoxicmicroenvironments in human colorectal cancer.
    Cancer Lett. 2017 Jun 7. pii: S0304-3835(17)30347.
    >> Share

  32. DONG X, Liao W, Zhang L, Tu X, et al
    RSPO2 suppresses colorectal cancer metastasis by counteracting the Wnt5a/Fzd7-driven noncanonical Wnt pathway.
    Cancer Lett. 2017 Jun 6. pii: S0304-3835(17)30370.
    >> Share

  33. NAGARAJU GP, Wu C, Merchant N, Chen Z, et al
    Epigenetic effects of inhibition of heat shock protein 90 (HSP90) in human pancreatic and colon cancer.
    Cancer Lett. 2017 Jun 3. pii: S0304-3835(17)30357.
    >> Share

    May 2017
  34. NAKAMURA Y, Hattori N, Iida N, Yamashita S, et al
    Targeting of super-enhancers and mutant BRAF can suppress growth of BRAF-mutant colon cancer cells via repression of MAPK signaling pathway.
    Cancer Lett. 2017 May 31. pii: S0304-3835(17)30353.
    >> Share

  35. LIN F, Zhang P, Zuo Z, Wang F, et al
    Thioredoxin-1 Promotes Colorectal Cancer Invasion and Metastasis through Crosstalk with S100P.
    Cancer Lett. 2017 May 5. pii: S0304-3835(17)30308.
    >> Share

  36. XIANG J, Sun H, Su L, Liu L, et al
    Myocyte enhancer factor 2D promotes colorectal cancer angiogenesis downstream of hypoxia-inducible factor 1alpha.
    Cancer Lett. 2017 May 4. pii: S0304-3835(17)30309.
    >> Share

    April 2017
  37. DU C, Huang D, Peng Y, Yao Y, et al
    5-Fluorouracil Targets Histone Acetyltransferases p300/CBP in the Treatment of Colorectal Cancer.
    Cancer Lett. 2017 Apr 29. pii: S0304-3835(17)30294.
    >> Share

  38. OU C, Sun Z, Li X, Li X, et al
    MiR-590-5p, a density-sensitive microRNA, inhibits tumorigenesis by targeting YAP1 in colorectal cancer.
    Cancer Lett. 2017 Apr 19. pii: S0304-3835(17)30241.
    >> Share

    March 2017
  39. KOUSTAS E, Karamouzis MV, Mihailidou C, Schizas D, et al
    Co-targeting of EGFR and autophagy signaling is an emerging treatment strategy in metastatic colorectal cancer.
    Cancer Lett. 2017 Mar 18. pii: S0304-3835(17)30197.
    >> Share

  40. WANG YJ, Zhang YK, Zhang GN, Al Rihani SB, et al
    Regorafenib overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter in colorectal cancer: In vitro and in vivo study.
    Cancer Lett. 2017 Mar 13. pii: S0304-3835(17)30175.
    >> Share

  41. WOO IS, Jung YH
    Metronomic chemotherapy in metastatic colorectal cancer.
    Cancer Lett. 2017 Mar 5. pii: S0304-3835(17)30151.
    >> Share

    February 2017
  42. BADAWI A, Hehlgans S, Pfeilschifter J, Rodel F, et al
    Silencing of the mRNA-binding protein HuR increases the sensitivity of colorectal cancer cells to ionizing radiation through upregulation of caspase-2.
    Cancer Lett. 2017 Feb 17. pii: S0304-3835(17)30110.
    >> Share

  43. PAN Q, Meng L, Ye J, Wei X, et al
    Transcriptional repression of miR-200 family members by Nanog in colon cancer cells induces epithelial-mesenchymal transition (EMT).
    Cancer Lett. 2017 Feb 2. pii: S0304-3835(17)30081.
    >> Share

    January 2017
  44. EDER S, Arndt A, Lamkowski A, Daskalaki W, et al
    Baseline MAPK signaling activity confers intrinsic radioresistance to KRAS-mutant colorectal carcinoma cells by rapid upregulation of heterogeneous nuclear ribonucleoprotein K (hnRNP K).
    Cancer Lett. 2017;385:160-167.
    >> Share

  45. LIU R, Tang J, Ding C, Liang W, et al
    The depletion of ATM inhibits colon cancer proliferation and migration via B56gamma2-mediated Chk1/p53/CD44 cascades.
    Cancer Lett. 2017 Jan 13. pii: S0304-3835(17)30024.
    >> Share

  46. XIE R, Wang J, Tang W, Li Y, et al
    Rufy3 promotes metastasis through epithelial-mesenchymal transition in colorectal cancer.
    Cancer Lett. 2017 Jan 12. pii: S0304-3835(17)30015.
    >> Share

    December 2016
  47. LI Y, Oliver PG, Lu W, Pathak V, et al
    SRI36160 is a specific inhibitor of Wnt/beta-catenin signaling in human pancreatic and colorectal cancer cells.
    Cancer Lett. 2016 Dec 30. pii: S0304-3835(16)30800.
    >> Share

  48. CERDA MB, Lloyd R, Batalla M, Giannoni F, et al
    Silencing peroxiredoxin-2 sensitizes human colorectal cancer cells to ionizing radiation and oxaliplatin.
    Cancer Lett. 2016;388:312-319.
    >> Share

  49. HUANG GL, Zhang W, Ren HY, Zhou P, et al
    Oncogenic retinoic acid receptor alpha promotes human colorectal cancer growth through simultaneously regulating p21 transcription and GSK3beta/beta-catenin signaling.
    Cancer Lett. 2016 Dec 5. pii: S0304-3835(16)30743.
    >> Share

  50. WANG FF, Zhang XJ, Yan YR, Zhu XH, et al
    FBX8 is a metastasis suppressor downstream of miR-223 and targeting mTOR for degradation in colorectal cancer.
    Cancer Lett. 2016 Dec 1. pii: S0304-3835(16)30732.
    >> Share

    November 2016
  51. DONG R, Gong Y, Meng W, Yuan M, et al
    The involvement of M2 macrophage polarization inhibition in fenretinide-mediated chemopreventive effects on colon cancer.
    Cancer Lett. 2016 Nov 30. pii: S0304-3835(16)30717.
    >> Share

  52. YAN C, Luo L, Guo CY, Goto S, et al
    Doxorubicin-induced mitophagy contributes to drug resistance in cancer stem cells from HCT8 human colorectal cancer cells.
    Cancer Lett. 2016 Nov 30. pii: S0304-3835(16)30706.
    >> Share

  53. ZHANG WJ, Li Y, Wei MN, Chen Y, et al
    Synergistic antitumor activity of regorafenib and lapatinib in preclinical models of human colorectal cancer.
    Cancer Lett. 2016 Nov 15. pii: S0304-3835(16)30697.
    >> Share

  54. ABU LILA AS, Moriyoshi N, Fukushima M, Huang CL, et al
    Metronomic S-1 dosing and thymidylate synthase silencing have synergistic antitumor efficacy in a colorectal cancer xenograft model.
    Cancer Lett. 2016 Nov 9. pii: S0304-3835(16)30683.
    >> Share

  55. JO YK, Roh SA, Lee H, Park NY, et al
    Polypyrimidine tract-binding protein 1-mediated down-regulation of ATG10 facilitates metastasis of colorectal cancer cells.
    Cancer Lett. 2016;385:21-27.
    >> Share

  56. ZHOU P, Xiao N, Wang J, Wang Z, et al
    SMC1A recruits tumor-associated-fibroblasts (TAFs) and promotes colorectal cancer metastasis.
    Cancer Lett. 2016 Nov 4. pii: S0304-3835(16)30672.
    >> Share

  57. PLATET N, Hinkel I, Richert L, Murdamoothoo D, et al
    The tumor suppressor CDX2 opposes pro-metastatic biomechanical modifications of colon cancer cells through organization of the actin cytoskeleton.
    Cancer Lett. 2016 Nov 2. pii: S0304-3835(16)30671.
    >> Share

    October 2016
  58. DE MIGUEL D, Gallego Lleyda A, Ayuso JM, Pejenaute-Ochoa D, et al
    High-order TRAIL oligomer formation in TRAIL-coated lipid nanoparticles enhances DR5 cross-linking and increases antitumour effect against colon cancer.
    Cancer Lett. 2016 Oct 8. pii: S0304-3835(16)30612.
    >> Share

  59. DU J, Wang Y, Chen D, Ji G, et al
    BAY61-3606 potentiates the anti-tumor effects of TRAIL against colon cancer through up-regulating DR4 and down-regulating NF-kappaB.
    Cancer Lett. 2016 Oct 6. pii: S0304-3835(16)30609.
    >> Share

  60. WEN C, Chen J, Zhang D, Wang H, et al
    Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells.
    Cancer Lett. 2016 Oct 3. pii: S0304-3835(16)30549.
    >> Share

    September 2016
  61. MOLCK C, Ryall J, Failla LM, Coates JL, et al
    The A2b adenosine receptor antagonist PSB-603 promotes oxidative phosphorylation and ROS production in colorectal cancer cells via adenosine receptor-independent mechanism.
    Cancer Lett. 2016 Sep 28. pii: S0304-3835(16)30560.
    >> Share

    August 2016
  62. HU S, Dai H, Li T, Tang Y, et al
    Broad RTK-targeted therapy overcomes molecular heterogeneity-driven resistance to cetuximab via vectored immunoprophylaxis in colorectal cancer.
    Cancer Lett. 2016 Aug 26. pii: S0304-3835(16)30497.
    >> Share

  63. WANG R, Kang Y, Lohr CV, Fischer KA, et al
    Reciprocal regulation of BMF and BIRC5 (Survivin) linked to Eomes overexpression in colorectal cancer.
    Cancer Lett. 2016;381:341-348.
    >> Share

  64. ZHANG X, Chen Y, Hao L, Hou A, et al
    Macrophages induce resistance to 5-fluorouracil chemotherapy in colorectal cancer through the release of putrescine.
    Cancer Lett. 2016 Aug 8. pii: S0304-3835(16)30461.
    >> Share

    July 2016
  65. KONG J, Sun W, Li C, Wan L, et al
    Long non-coding RNA LINC01133 inhibits epithelial-mesenchymal transition and metastasis in colorectal cancer by interacting with SRSF6.
    Cancer Lett. 2016;380:476-484.
    >> Share

  66. OU B, Zhao J, Guan S, Wangpu X, et al
    Plk2 promotes tumor growth and inhibits apoptosis by targeting Fbxw7/Cyclin E in colorectal cancer.
    Cancer Lett. 2016 Jul 13. pii: S0304-3835(16)30398.
    >> Share

    June 2016
  67. TANABE A, Tanikawa K, Tsunetomi M, Takai K, et al
    RNA helicase YTHDC2 promotes cancer metastasis via the enhancement of the efficiency by which HIF-1alpha mRNA is translated.
    Cancer Lett. 2016;376:34-42.
    >> Share

  68. YOSHII Y, Furukawa T, Matsumoto H, Yoshimoto M, et al
    (64)Cu-ATSM therapy targets regions with activated DNA repair and enrichment of CD133(+) cells in an HT-29 tumor model: Sensitization with a nucleic acid antimetabolite.
    Cancer Lett. 2016;376:74-82.
    >> Share

  69. LU YX, Ju HQ, Wang F, Chen LZ, et al
    Inhibition of the NF-kappaB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis.
    Cancer Lett. 2016 Jun 17. pii: S0304-3835(16)30374.
    >> Share

    May 2016
  70. KUO CT, Lee WS
    Progesterone receptor activation is required for folic acid-induced anti-proliferation in colorectal cancer cell lines.
    Cancer Lett. 2016;378:104-110.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016